Literature DB >> 8471681

Does ECT permanently alter seizure threshold?

R B Krueger1, J M Fama, D P Devanand, J Prudic, H A Sackeim.   

Abstract

Recent research has raised the possibility that electroconvulsive therapy (ECT) results in a persistent elevation of seizure threshold among males. In this study, seizure threshold, quantified by the method of limits procedure, was assessed at the first and last treatments of 148 consecutive depressed patients. Patients with and without a prior history of ECT did not differ in seizure threshold at the first treatment, seizure duration at the first treatment or averaged across all treatments, or in the magnitude of the seizure threshold increase over the ECT course. No evidence was obtained that history of ECT was associated with alterations of seizure threshold or seizure duration.

Entities:  

Mesh:

Year:  1993        PMID: 8471681     DOI: 10.1016/0006-3223(93)90294-n

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  The ictal electroencephalogram as a marker for the efficacy of electroconvulsive therapy.

Authors:  H Folkerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

2.  No long-lasting effects of electroconvulsive therapy on resistance to seizure induction.

Authors:  C M Swartz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 3.  [Electric brain stimulation for epilepsy therapy].

Authors:  C Kellinghaus; T Loddenkemper; G Möddel; F Tergau; J Lüders; P Lüdemann; D R Nair; H O Lüders
Journal:  Nervenarzt       Date:  2003-08       Impact factor: 1.214

Review 4.  The anticonvulsant effect of electrical fields.

Authors:  S Weinstein
Journal:  Curr Neurol Neurosci Rep       Date:  2001-03       Impact factor: 6.030

5.  Clinical predictors of seizure threshold in electroconvulsive therapy: a prospective study.

Authors:  Jeroen A van Waarde; Lucas J B van Oudheusden; Bastiaan Verwey; Erik J Giltay; Rose C van der Mast
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-07-15       Impact factor: 5.270

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.